CytomX Therapeutics Inc
CTMX
Market Cap$155.84M
Close$
$6.51
244.7% upside
Current Fair Value
244.7% upsideUndervalued by 244.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $155.84 Million |
|---|---|
| Enterprise Value | $5.55 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.21 |
| Beta | 0.0 |
| Outstanding Shares | 77,919,369 |
| Avg 30 Day Volume | 7,574,994 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 9.43 |
|---|---|
| PEG | -1.82 |
| Price to Sales | 1.89 |
| Price to Book Ratio | -1.89 |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 0.51 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CytomX Therapeutics Inc
CEO: Sean McCarthy